Keefe, Bruyette & Woods Cuts MetLife (NYSE:MET) Price Target to $95.00

MetLife (NYSE:METFree Report) had its target price cut by Keefe, Bruyette & Woods from $98.00 to $95.00 in a research note released on Wednesday morning,Benzinga reports. They currently have an outperform rating on the financial services provider’s stock.

Several other research analysts also recently issued reports on the stock. BMO Capital Markets started coverage on shares of MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 target price on the stock. Wells Fargo & Company increased their target price on MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research note on Wednesday, February 19th. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Piper Sandler increased their price objective on MetLife from $92.00 to $94.00 and gave the company an “overweight” rating in a research report on Wednesday, April 2nd. Finally, Morgan Stanley boosted their target price on MetLife from $101.00 to $109.00 and gave the stock an “overweight” rating in a research report on Friday, February 28th. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $92.46.

Check Out Our Latest Stock Report on MET

MetLife Stock Up 0.2 %

MET stock opened at $71.25 on Wednesday. The business has a 50 day moving average of $80.32 and a 200 day moving average of $82.46. The firm has a market cap of $48.54 billion, a PE ratio of 11.94, a price-to-earnings-growth ratio of 0.65 and a beta of 0.89. MetLife has a twelve month low of $65.21 and a twelve month high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54.

MetLife (NYSE:METGet Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, research analysts forecast that MetLife will post 9.65 EPS for the current fiscal year.

Institutional Trading of MetLife

Several large investors have recently added to or reduced their stakes in the business. Ball & Co Wealth Management Inc. purchased a new position in shares of MetLife during the 4th quarter worth $25,000. Transce3nd LLC purchased a new position in MetLife during the fourth quarter valued at $26,000. Quarry LP purchased a new stake in MetLife in the fourth quarter worth about $31,000. Sierra Ocean LLC bought a new position in shares of MetLife in the fourth quarter worth about $32,000. Finally, Retirement Wealth Solutions LLC purchased a new position in shares of MetLife during the 4th quarter valued at about $32,000. 94.99% of the stock is currently owned by institutional investors.

About MetLife

(Get Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.